Article citationsMore>>
Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I., Snow, B.E., Brothers, G.M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D.R., Aebersold, R., Siderovski, D.P., Penninger, J.M. and Kroemer, G. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397, 441-446.
doi:10.1038/17135
has been cited by the following article:
-
TITLE:
Bax promoter G(-248)A polymorphism in a Turkish clinical breast cancer patients: A case-control study
AUTHORS:
Yemliha Yildiz, Ilhan Yaylim, Nazli Ezgi Ozkan, Soykan Arikan, Saime Turan, Seden Kucucuk, Ender Coskunpinar, Turgay Isbir
KEYWORDS:
Bcl-2 Associated-X-Protein; SNP; Apoptosis; PCR; Susceptibility; Carcinogenesis
JOURNAL NAME:
American Journal of Molecular Biology,
Vol.3 No.1,
January
23,
2013
ABSTRACT: Bax is an important protein involved in apoptotic process. Mutations of the Bax gene are known to af- fect protein expression and function. A promotor polymorphism G(-248)A in the 5’UTR of Bax gene may alter regulation of apoptosis in carcinogenesis. Our study was performed to test the association be- tween G(-248)A polymorphisms in the Bax gene and breast cancer risk and progression. G(-248)A poly- morphism was genotyped in a Turkish breast cancer, case-control population including 53 female cancer patients (mean age ± SD: 60.9 ± 11.9 years) and 82 controls (mean age ± SD: 57.2 ± 17.5 years) using PCR-RFLP analysis. Genotype and allele frequencies were assessed with the chi-square test. There was no difference in the distribution of Bax genotypes, and allele frequencies were G (87.7% versus 88.4%) and A (12.3% versus 11.6%) in the cancer patients and controls, respectively. Within the cancer group, the presence of a polymorphic Bax G(-248)A allele was not associated with clinico-pathological parameters such as advanced tumor stage, lymph node or distant metastasis. We present the first to report on Bax G(-248)A polymorphisms in breast cancer. Our re- sults suggest that Bax G(-248)A polymorphism do not modify individual susceptibility to invasive breast cancer in Turkish women.
Related Articles:
-
Caitlin R. Philippi, John W. Zeller, Nibir K. Dhar, Priyalal Wijewarnasuriya, Ashok K. Sood, Harry Efstathiadis
-
Cheng Chang, Xiaoyong Liu, Keping Chen
-
Mikhail Yu. Gorbachev, Natalia N. Gorinchoy
-
Abdellatif Bouzidi, Ahmed S. Bouazzi, Mosbah Amlouk
-
Miroslav Kureš